ARID1A mutation may define an immunologically active subgroup in patients with microsatellite-stable colorectal cancer

INTRODUCTION: ARID1A is commonly mutated in colorectal cancer (CRC), frequently resulting in truncation and loss of protein expression. ARID1A recruits MSH2 for mismatch-repair during DNA replication. ARID1A deficiency promotes hypermutability and immune activation in preclinical models but its role...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Mehrvarz Sarshekeh, Amir, Alshenaifi, Jumanah, Roszik, Jason, Manyam, Ganiraju C., Advani, Shailesh M., Katkhuda, Riham, Verma, Anuj, Lam, Michael, Willis, Jason, Shen, John Paul, Morris, Jeffrey, Davis, Jennifer S., Loree, Jonathan M., Lee, Hey Min, Ajani, Jaffer A., Maru, Dipen M., Overman, Michael J., Kopetz, Scott
Formato: Artigo
Idioma:Inglês
Publicado em: 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7956157/
https://ncbi.nlm.nih.gov/pubmed/33414133
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-20-2404
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados